Literature DB >> 8416770

The epidemiology of lung cancer.

J M Samet1.   

Abstract

Lung cancer rates and mortality have risen in epidemic proportions in the United States and other industrialized nations during the 20th century. Case-control and cohort studies performed in the 1950s and 1960s firmly established cigarette smoking as the single greatest risk factor for lung cancer. In the United States, overall lung cancer mortality rates in men and women rose progressively from the 1950s. Fortunately, lung cancer incidence and mortality are now declining in middle-aged men. Smoking has significantly increased lung cancer rates among women and is on the rise in developing countries. Environmental agents found in the home and workplace, including radon and asbestos, have also been shown to increase lung cancer risk in both smokers and nonsmokers. Government regulations have helped curtail quantities of these and other atmospheric carcinogens. Efforts to reduce lung cancer risk must be continued and their scope expanded in order to have a global impact on the incidence and mortality of this fatal malignancy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416770     DOI: 10.1378/chest.103.1_supplement.20s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort.

Authors:  Chad A Bousman; Cheryl Rivard; Jason Den Haese; Christine Ambrosone; Andrew Hyland
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-01-05       Impact factor: 3.568

2.  P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects.

Authors:  Chao Zhou; Hao Chen; An Wang
Journal:  Tumour Biol       Date:  2013-05-30

3.  Screening in the dark: ethical considerations of providing screening tests to individuals when evidence is insufficient to support screening populations.

Authors:  Ingrid M Burger; Nancy E Kass
Journal:  Am J Bioeth       Date:  2009-04       Impact factor: 11.229

4.  Variation in lung cancer risk by smoky coal subtype in Xuanwei, China.

Authors:  Qing Lan; Xingzhou He; Min Shen; Linwei Tian; Larry Z Liu; Hong Lai; Wei Chen; Sonja I Berndt; Howard Dean Hosgood; Kyoung-Mu Lee; Tongzhang Zheng; Aaron Blair; Robert S Chapman
Journal:  Int J Cancer       Date:  2008-11-01       Impact factor: 7.396

5.  Nicotinic receptor gene variants influence susceptibility to heavy smoking.

Authors:  Victoria L Stevens; Laura J Bierut; Jeffrey T Talbot; Jen C Wang; Juzhong Sun; Anthony L Hinrichs; Michael J Thun; Alison Goate; Eugenia E Calle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11-24       Impact factor: 4.254

Review 6.  Early glandular neoplasia of the lung.

Authors:  W H Westra
Journal:  Respir Res       Date:  2000-11-17

7.  FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer.

Authors:  Gareth O Griffiths; Sarah Burns; Simon I Noble; Fergus R Macbeth; David Cohen; Timothy S Maughan
Journal:  BMC Cancer       Date:  2009-10-06       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.